Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CONNEQT Health is an Australian-listed health technology and medical device company focused on arterial health assessment, vascular biomarkers, and cardiovascular monitoring. The company commercializes SphygmoCor-powered products for clinic, research, pharmaceutical trial, and home-use settings, including the CONNEQT Pulse and SphygmoCor XCEL systems. Its offerings are used to measure central blood pressure, arterial stiffness, and related vascular health markers that go beyond conventional cuff blood pressure. CONNEQT serves clinicians, researchers, pharmaceutical companies, and consumers, positioning itself at the intersection of cardiovascular diagnostics, remote monitoring, and digital health. The business was formerly known as CardieX and rebranded to CONNEQT Health in 2025 to unify its consumer and professional product lines under a single brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CONNEQT Health.